CL
BMY icon

COWA LLC’s Bristol-Myers Squibb BMY Stock Holding History

COWA LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Sell
20,323
-825
-4% -$47.4K 0.29% 53
2026
Q1 		$1.28M Buy
21,148
+1,982
+10% +$116K 0.35% 45
2025
Q4 		$1.03M Sell
19,166
-38
-0.2% -$1.83K 0.31% 50
2025
Q3 		$866K Buy
19,204
+737
+4% +$34.4K 0.29% 62
2025
Q2 		$855K Buy
18,467
+515
+3% +$25.3K 0.33% 61
2025
Q1 		$1.09M Buy
17,952
+982
+6% +$57.2K 0.47% 45
2024
Q4 		$960K Buy
16,970
+5,017
+42% +$280K 0.44% 47
2024
Q3 		$618K Buy
11,953
+2,048
+21% +$96.1K 0.29% 69
2024
Q2 		$411K Buy
9,905
+550
+6% +$24.6K 0.22% 85
2024
Q1 		$507K Buy
9,355
+2,021
+28% +$103K 0.3% 68
2023
Q4 		$376K Buy
7,334
+1,071
+17% +$56.2K 0.23% 77
2023
Q3 		$364K Sell
6,263
-1,058
-14% -$64.8K 0.25% 71
2023
Q2 		$468K Buy
7,321
+19
+0.3% +$1.27K 0.31% 61
2023
Q1 		$506K Sell
7,302
-99
-1% -$6.98K 0.41% 58
2022
Q4 		$532K Sell
7,401
-802
-10% -$60.5K 0.33% 64
2022
Q3 		$583K Sell
8,203
-8,008
-49% -$581K 0.38% 57
2022
Q2 		$1.25M Sell
16,211
-367
-2% -$28K 0.72% 33
2022
Q1 		$1.21M Sell
16,578
-206
-1% -$13.8K 0.6% 36
2021
Q4 		$1.05M Buy
16,784
+381
+2% +$22.4K 0.53% 35
2021
Q3 		$971K Sell
16,403
-7,121
-30% -$469K 0.56% 35
2021
Q2 		$1.57M Sell
23,524
-248
-1% -$16.2K 0.98% 22
2021
Q1 		$1.49M Buy
23,772
+16,109
+210% +$1M 0.9% 22
2020
Q4 		$496K Buy
+7,663
New +$471K 0.38% 57

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

COWA LLC's BMY Position: Q2 2026 in Review

COWA LLC reduced its Bristol-Myers Squibb (BMY) stake by 3.9% in Q2 2026, selling an estimated $47.4K and leaving 20,323 shares worth $1.17M. The position accounts for 0.29% of the portfolio, ranked #53.

COWA LLC first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.57M in Q2 2021. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • COWA LLC held 20,323 shares of Bristol-Myers Squibb worth $1.17M as of Q2 2026.
  • COWA LLC sold 825 Bristol-Myers Squibb shares in Q2 2026, an estimated $47.4K.
  • Bristol-Myers Squibb made up 0.29% of COWA LLC's portfolio in Q2 2026, its #53 holding.
  • COWA LLC first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • COWA LLC's Bristol-Myers Squibb position peaked at $1.57M in Q2 2021.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on COWA LLC's 13F filing for Q2 2026, filed 6 Aug 2026.